Immunology

  1. In silico Design of novel Multi-epitope recombinant Vaccine based on Coronavirus surface glycoprotein

    1. Mandana Behbahani

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques

    1. Carolina Garrido
    2. Alan D. Curtis
    3. Maria Dennis
    4. Sachi H. Pathak
    5. Hongmei Gao
    6. David Montefiori
    7. Mark Tomai
    8. Christopher B. Fox
    9. Pamela A. Kozlowski
    10. Trevor Scobey
    11. Jennifer E. Munt
    12. Michael L. Mallory
    13. Pooja T. Saha
    14. Michael G. Hudgens
    15. Lisa C. Lindesmith
    16. Ralph S. Baric
    17. Olubukola M. Abiona
    18. Barney S. Graham
    19. Kizzmekia S. Corbett
    20. Darin Edwards
    21. Andrea Carfi
    22. Genevieve Fouda
    23. Koen K. A. Van Rompay
    24. Kristina De Paris
    25. Sallie R. Permar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant

    1. Venkata Viswanadh Edara
    2. Carson Norwood
    3. Katharine Floyd
    4. Lilin Lai
    5. Meredith E. Davis-Gardner
    6. William H. Hudson
    7. Grace Mantus
    8. Lindsay E. Nyhoff
    9. Max W. Adelman
    10. Rebecca Fineman
    11. Shivan Patel
    12. Rebecca Byram
    13. Dumingu Nipuni Gomes
    14. Garett Michael
    15. Hayatu Abdullahi
    16. Nour Beydoun
    17. Bernadine Panganiban
    18. Nina McNair
    19. Kieffer Hellmeister
    20. Jamila Pitts
    21. Joy Winters
    22. Jennifer Kleinhenz
    23. Jacob Usher
    24. James B. O’Keefe
    25. Anne Piantadosi
    26. Jesse J. Waggoner
    27. Ahmed Babiker
    28. David S. Stephens
    29. Evan J. Anderson
    30. Srilatha Edupuganti
    31. Nadine Rouphael
    32. Rafi Ahmed
    33. Jens Wrammert
    34. Mehul S. Suthar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Binding Mechanism of Neutralizing Nanobodies Targeting SARS-CoV-2 Spike Glycoprotein

    1. Mert Golcuk
    2. Aysima Hacisuleyman
    3. Burak Erman
    4. Ahmet Yildiz
    5. Mert Gur

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants

    1. Aaron J. Schmitz
    2. Jackson S. Turner
    3. Zhuoming Liu
    4. Julian Q. Zhou
    5. Ishmael D. Aziati
    6. Rita E. Chen
    7. Astha Joshi
    8. Traci L. Bricker
    9. Tamarand L. Darling
    10. Daniel C. Adelsberg
    11. Clara G. Altomare
    12. Wafaa B. Alsoussi
    13. James Brett Case
    14. Laura A. VanBlargan
    15. Tingting Lei
    16. Mahima Thapa
    17. Fatima Amanat
    18. Trushar Jeevan
    19. Thomas Fabrizio
    20. Jane A. O’Halloran
    21. Pei-Yong Shi
    22. Rachel M. Presti
    23. Richard J. Webby
    24. Florian Krammer
    25. Sean P.J. Whelan
    26. Goran Bajic
    27. Michael S. Diamond
    28. Adrianus C.M. Boon
    29. Ali H. Ellebedy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Mice Immunized with the Vaccine Candidate HexaPro Spike Produce Neutralizing Antibodies against SARS-CoV-2

    1. Chotiwat Seephetdee
    2. Nattawut Buasri
    3. Kanit Bhukhai
    4. Kitima Srisanga
    5. Suwimon Manopwisedjaroen
    6. Sarat Lertjintanakit
    7. Nut Phueakphud
    8. Chatbenja Pakiranay
    9. Niwat Kangwanrangsan
    10. Sirawat Srichatrapimuk
    11. Suppachok Kirdlarp
    12. Somnuek Sungkanuparph
    13. Somchai Chutipongtanate
    14. Arunee Thitithanyanont
    15. Suradej Hongeng
    16. Patompon Wongtrakoongate

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. SARS-CoV-2 variant with higher affinity to ACE2 shows reduced sera neutralization susceptibility

    1. Monique Vogel
    2. Xinyue Chang
    3. Gilles Sousa Augusto
    4. Mona O. Mohsen
    5. Daniel E. Speiser
    6. Martin F. Bachmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. LL-37 fights SARS-CoV-2: The Vitamin D-Inducible Peptide LL-37 Inhibits Binding of SARS-CoV-2 Spike Protein to its Cellular Receptor Angiotensin Converting Enzyme 2 In Vitro

    1. Annika Roth
    2. Steffen Lütke
    3. Denise Meinberger
    4. Gabriele Hermes
    5. Gerhard Sengle
    6. Manuel Koch
    7. Thomas Streichert
    8. Andreas R. Klatt

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection

    1. Abigael Eva Chaouat
    2. Hagit Achdout
    3. Inbal Kol
    4. Orit Berhani
    5. Gil Roi
    6. Einat B. Vitner
    7. Sharon Melamed
    8. Boaz Politi
    9. Eran Zahavy
    10. Ilija Brizic
    11. Tihana Lenac Rovis
    12. Or Alfi
    13. Dana Wolf
    14. Stipan Jonjic
    15. Tomer Israely
    16. Ofer Mandelboim

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins

    1. George Lagoumintzis
    2. Christos T. Chasapis
    3. Nikolaos Alexandris
    4. Dimitrios Kouretas
    5. Socrates Tzartos
    6. Elias Eliopoulos
    7. Konstantinos Farsalinos
    8. Konstantinos Poulas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 165 of 175 Next